14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.98 $1.48 Friday, 17th May 2024 ALLK stock ended at $1.44. This is 0.690% less than the trading day before Thursday, 16th May 2024. During the day the stock fluctuated 7.35% from a day low at $1.36 to a day high of $1.46.
90 days $0.98 $1.69
52 weeks $0.98 $5.64

Historical Allakos Inc. prices

Date Open High Low Close Volume
Aug 13, 2018 $38.54 $41.05 $37.31 $39.31 155 588
Aug 10, 2018 $36.71 $40.33 $36.71 $38.92 407 968
Aug 09, 2018 $37.06 $40.91 $36.78 $37.27 420 478
Aug 08, 2018 $39.60 $39.85 $36.33 $36.78 260 259
Aug 07, 2018 $40.13 $41.00 $39.60 $39.85 160 518
Aug 06, 2018 $41.25 $42.45 $38.26 $39.69 271 623
Aug 03, 2018 $41.03 $42.84 $40.61 $41.02 101 558
Aug 02, 2018 $41.01 $42.94 $40.02 $41.36 195 015
Aug 01, 2018 $41.51 $45.95 $40.69 $40.95 434 854
Jul 31, 2018 $39.78 $43.96 $39.50 $40.77 175 140
Jul 30, 2018 $39.84 $40.40 $39.00 $40.00 63 773
Jul 27, 2018 $40.00 $40.83 $39.04 $39.79 135 106
Jul 26, 2018 $39.50 $40.45 $39.17 $39.97 369 580
Jul 25, 2018 $38.30 $40.14 $37.82 $39.30 543 596
Jul 24, 2018 $36.24 $38.83 $35.09 $38.12 293 841
Jul 23, 2018 $35.05 $38.53 $34.00 $36.29 1 008 721
Jul 20, 2018 $30.29 $37.00 $30.25 $35.05 698 128
Jul 19, 2018 $27.20 $33.24 $26.00 $31.25 4 438 188

FAQ

What are historical stock prices?
Historical stock prices refer to a stock’s recorded prices at various past points. These prices include several key figures that help investors and analysts evaluate a stock’s performance over time:
Open: Open price for the trading day.
High: Highest price for the trading day.
Low: Lowest price for the trading day.
Close: Close price for the trading day.

Additionally, historical prices often include:
Volume is the number of shares traded during the day. It indicates how actively a stock was traded and can provide insights into market sentiment and liquidity.

How can I use ALLK stock historical prices to predict future price movements?
Trend Analysis: Examine the ALLK stock’s historical trends to identify patterns that might continue.
Moving Averages: Use moving averages to detect potential reversal points.
Momentum Indicators: Apply indicators like RSI or MACD to assess the momentum and strength of price movements.
Volume Analysis: Analyze trading volume alongside price changes to gauge trend strength.
Statistical Methods: Use statistical tools such as regression analysis to model and forecast future prices based on past data.
These techniques can provide insights but should be used with risk management practices to mitigate potential losses.

What impact do stock splits have on historical price data?
When a company performs a stock split, it adjusts the historical price data to reflect the new, lower trading price as if it had always been that way.

This ensures consistency for anyone analyzing the stock’s past prices. The adjustment helps prevent misleading signals on charts, such as false sell signals or bearish trends that aren’t there. For instance, in a 2-for-1 stock split, the price per share is cut in half, which would otherwise appear as a dramatic drop on the chart. If someone didn’t know about the split, they might wrongly think something negative happened to the company. Most technical indicators would also react to this apparent drop by signaling to sell.

A stock split, while making the shares seem more affordable and potentially more attractive to investors, doesn’t alter the company’s fundamental value.

Why do the ALLK stock historical prices show a range for periods like 30 days, 90 days, and 52 weeks?
The range provides the lowest and highest prices at which the stock has traded during the specified period. This helps investors understand the stock’s volatility and price variability within that timeframe.

How can I use historical price volatility to assess risk?
High price volatility historically indicates higher risk and potentially higher returns. Investors can gauge the stock’s risk level by examining the range between high and low prices over various periods.
Click to get the best stock tips daily for free!

About Allakos Inc.

Allakos. Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; a Phase II/III study for eosinophilic esophagitis; and a Phase II clinical... ALLK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT